Publication Information

{'id': 'https://openalex.org/W4249661869', 'doi': 'https://doi.org/10.1016/j.jaad.2015.02.1007', 'title': 'Starting-dose trends over time in biologic-naïve and biologic-experienced psoriasis patients initiated on ustekinumab or adalimumab', 'display_name': 'Starting-dose trends over time in biologic-naïve and biologic-experienced psoriasis patients initiated on ustekinumab or adalimumab', 'publication_year': 2015, 'publication_date': '2015-05-01', 'ids': {'openalex': 'https://openalex.org/W4249661869', 'doi': 'https://doi.org/10.1016/j.jaad.2015.02.1007'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.jaad.2015.02.1007', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S58727509', 'display_name': 'Journal of the American Academy of Dermatology', 'issn_l': '0190-9622', 'issn': ['0190-9622', '1097-6787'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4200, 'currency': 'USD', 'value_usd': 4200, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': '72', 'issue': '5', 'first_page': 'AB253', 'last_page': 'AB253'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11117', 'display_name': 'Drug-Induced Adverse Reactions', 'score': 0.9927, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11725', 'display_name': 'Immunodeficiency and Autoimmune Disorders', 'score': 0.9874, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ustekinumab', 'display_name': 'Ustekinumab', 'score': 0.9770298}, {'id': 'https://openalex.org/keywords/biologic-agents', 'display_name': 'Biologic Agents', 'score': 0.4859711}, {'id': 'https://openalex.org/keywords/dermatologic-agents', 'display_name': 'Dermatologic agents', 'score': 0.4480536}], 'concepts': [{'id': 'https://openalex.org/C2778975655', 'wikidata': 'https://www.wikidata.org/wiki/Q420305', 'display_name': 'Ustekinumab', 'level': 4, 'score': 0.9770298}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9717083}, {'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.94381404}, {'id': 'https://openalex.org/C2780564577', 'wikidata': 'https://www.wikidata.org/wiki/Q179945', 'display_name': 'Psoriasis', 'level': 2, 'score': 0.7618848}, {'id': 'https://openalex.org/C3020604521', 'wikidata': 'https://www.wikidata.org/wiki/Q179945', 'display_name': 'Plaque psoriasis', 'level': 3, 'score': 0.6289542}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.5675647}, {'id': 'https://openalex.org/C2911221801', 'wikidata': 'https://www.wikidata.org/wiki/Q2742406', 'display_name': 'Biologic Agents', 'level': 3, 'score': 0.4859711}, {'id': 'https://openalex.org/C2910774642', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatologic agents', 'level': 3, 'score': 0.4480536}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.34422296}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.1454927}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.09207249}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C89423630', 'wikidata': 'https://www.wikidata.org/wiki/Q7193', 'display_name': 'Microbiology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C501593827', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotics', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.jaad.2015.02.1007', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S58727509', 'display_name': 'Journal of the American Academy of Dermatology', 'issn_l': '0190-9622', 'issn': ['0190-9622', '1097-6787'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Zero hunger', 'id': 'https://metadata.un.org/sdg/2', 'score': 0.57}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4245548033', 'https://openalex.org/W4244333737', 'https://openalex.org/W2791230081', 'https://openalex.org/W2766130161', 'https://openalex.org/W2416086385', 'https://openalex.org/W2415742554', 'https://openalex.org/W2063221074', 'https://openalex.org/W2008995310', 'https://openalex.org/W1886965810', 'https://openalex.org/W1556799085'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4249661869', 'counts_by_year': [], 'updated_date': '2024-12-06T00:00:06.435883', 'created_date': '2022-05-12'}